Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3

BACKGROUND: Antibody resistance, not only de novo but also acquired cases, usually exists and is related with lower survival rate and high risk of recurrence. Reversing the resistance often results in better clinical therapeutic effect. Previously, we established a trastuzumab-resistant ovarian canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Ovarian Res
Main Authors: Wang, Wei, Zhang, Yan, Lv, Ming, Feng, Jiannan, Peng, Hui, Geng, Jing, Lin, Zhou, Zhou, Tingting, Li, Xinying, Shen, Beifen, Ma, Yuanfang, Qiao, Chunxia
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260252/
https://ncbi.nlm.nih.gov/pubmed/25424625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-014-0103-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados